Tsur David received 37,500 KAMADA LTD derivative securities across two transactions dated 2026-08-27, with each recorded at $0 per share. The disclosure gives investors a defined post-transaction position of 30,000 derivative securities and identifies the entries as awards or grants rather than market purchases.
Key Highlights
- Tsur David’s two transactions covered a total of 37,500 derivative securities.
- The transactions were recorded on 27 August 2026 at $0 per share.
- His reported position after the transactions was 30,000 derivative securities.
KAMADA LTD (NASDAQ: KMDA) is a biotechnology company. Director Tsur David received 37,500 derivative securities through two transactions dated 27 August 2026, with the securities recorded at $0 per share. His reported position after those transactions was 30,000 derivative securities.
KAMADA Director Award Details
The combined amount awarded to David was 37,500. Each transaction carried a price of $0 per share, and both were dated 27 August 2026. Tsur David is identified as a director of KAMADA LTD.
FAQs
Q: How many derivative securities did Tsur David receive from KAMADA LTD?
A: Tsur David received 37,500 KAMADA LTD derivative securities across two transactions.
Q: At what price were Tsur David’s KAMADA LTD securities awarded?
A: The derivative securities were recorded at $0 per share. The two transactions took place on 27 August 2026.
Q: How many derivative securities did Tsur David hold afterward?
A: Tsur David’s disclosed position after the transactions was 30,000 derivative securities of KAMADA LTD. He is identified as a director.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.